bpc-157 safety human study clinical trial trials rcts bpc-157 human clinical trials rcts bpc-157 human trials Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature-bsmoothhr bpc-157 human clinical trials evidence The Hidden Risks of BPC‑157:

10 , e1004772 (2014)

Research from a 2023 article found significant mitochondrial structural and functional abnormalities in the muscle cells of long COVID patients, including: Disrupted cristae (mitochondrial) architecture Impaired electron transport chain function Reduced ATP production capacity These findings mirror what we see in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a condition that shares significant overlap with long COVID and is now thought to involve similar mitochondrial pathology

One review describes BPC-157 as active across the GI tract and studied in IBD, including ulcerative colitis, in BPC-157 in IBD

Gut Health: Given its origin, it's no surprise that a massive body of research centers on its protective effects on the gastrointestinal tract, from the esophagus to the colon